Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Withdrawn 1Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Head & Neck 1Gastrointestinal 1

Conditions

Weight Loss 1Pancreatic Neoplasms 1Neoplasms 1Neoplasm Metastasis 1Malnutrition 1Lung Neoplasms 1Head and Neck Neoplasms 1Body Weight 1

Interventions

Gemcitabine 100130-nm albumin-bound paclitaxel 34Oxaliplatin 28Capecitabine 27Fluorouracil 25Albumin-Bound Paclitaxel 23Leucovorin 19Irinotecan 18Erlotinib Hydrochloride 14Cyclophosphamide 12Radiosurgery 11pembrolizumab 10Radiotherapy 10Nivolumab 10Bevacizumab 10Surgical Procedures, Operative 9avelumab 7Docetaxel 7Taxes 6Cisplatin 6ruxolitinib 5folfirinox 5Specimen Handling 5Paclitaxel 5Everolimus 5Cetuximab 5ALT-803 5trametinib 4spartalizumab 4fludarabine 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Pancreatic Neoplasms × Mirtazapine × Clear all
NCT04155008 2022-11-16

Nutrition and Pharmacological Algorithm for Oncology Patients Study

Montefiore Medical Center

Phase 4 Terminated
1 enrolled 5 charts
GastrointestinalHead & NeckThoracic

Head and Neck Neoplasms, Lung Neoplasms, Pancreatic Neoplasms, Malnutrition

Data powered by HemOnc (CC BY 4.0) Colophon âš¡